Oncology News

Pending data by year-end, we expect GILD to pay above fair value >100% upside for MGNX, reflecting its scarcity value delivering both immuno-oncology exposure and high-throughput drug development.

ROS1 fusion genes were successfully detected independent of gender or smoking history in young East Asian patients with lung adenocarcinoma , a histological subgroup in non-small cell lung cancer , using multiplex reverse transcriptase-polymerase chain reaction and immunohistochemistry diagnostic tests.

Exchange-traded funds offer a convenient way to invest in sectors or niches that interest you.

While she always wanted to be a doctor, she first provided care as a nurse, and some of her early experiences helping cancer patients encouraged her to specialize in radiation oncology as a physician.

The provincial budget is a factor when it comes to delays in approving new cancer drugs, say P.E.I. health officials.

At the same time, mortality due to cancer cases is estimated to be at 0.8 million, Health Minister Harsh Vardhan told the Rajya Sabha in a written reply.

Advaxis, Inc. , a clinical-stage biotechnology company developing cancer immunotherapies, has entered into a clinical trial collaboration with MedImmune, the global biologics research and development arm of AstraZeneca.

The University of Texas MD Anderson Cancer Center is pleased to announce that one of the world's preeminent experts in breast cancer research and treatment, V. Craig Jordan, Ph.D., will join the institution's efforts to end cancer.

Jordan Foster is only five years old, but her father told WAVY.com she saw ads about hosting lemonade stands for Anthem's LemonAid for Children's Miracle Network Hospitals and decided to participate.

Twenty years ago, Pam Roberts was diagnosed with breast cancer. Every week through treatment and rehabilitation, Roberts attended a writing workshop, where she found that no matter what prompt was given, she'd write about her experience with cancer.

Champions Oncology , a company engaged in the development of advanced technology solutions and services to personalize the development and use of oncology drugs, today announced it will report its financial and operational results for the fourth quarter and fiscal year ended April 30, 2014, on Thursday, July 24, 2014, after market close.

This clinical trial is called STARTRK-1, which stands for A/B/C, and is a Phase I/IIa, multicenter, single-arm, open-label clinical trial of continuous daily dosing of oral RXDX-101 in adult patients with locally advanced or metastatic cancer confirmed to be positive for relevant molecular alterations.

In what's being described as a significant show of support for immunotherapy research in the treatment of cancer, the National Institutes of Health has awarded a $1.6 million, five-year grant to a Providence Cancer Center researcher.

Ballarat Regional Integrated Cancer Centre director Steve Medwell shows the facility to a delegation from Peter's Project in Warrnambool.

The monthly health care industry publication, Becker's Hospital Review , released its list of "500+ People to Know in Healthcare."

A breast cancer patient died after a delay of nearly two years in informing her of her positive test results.

Cancer survivor Randy Childress joked that the disease was a great weight loss program when he was sick in the late '90s, but 20 years of medical advances have continually improved the quality of life for survivors of the disease.

Breast cancer claims thousands of innocent lives across the globe every year. Based on the different stages of breast cancer, the doctors decide on the mode of treatment.

Like a lot of teen girls, Faith Brown has read The Fault in Our Stars, the popular novel about two teens who fall in love at a cancer support group.

Cancer Council Victoria is campaigning for improvements to the Victorian Patient Transport Assistance Scheme ahead of this year's Victorian election.